Acute Diverticulitis and C-Reactive Protein as a Prognost... | NCT01825967

Studies
Acute Diverticulitis and C-Reactive Protein as a Prognostic Marker

NCT01825967

Sponsor

Corporacion Parc Tauli

Status

Unknown status

Last Update Posted

Apr 10, 2013Estimated

Enrollment

30Estimated

Phase

Not provided

Conditions

Acute Diverticulitis

Interventions

C-reactive protein

Countries

Spain

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

Apr 2013

Overall Recruitment Status or Expanded Access Status

Unknown status

Last Known Status

Not yet recruiting

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Apr 2013

Primary Completion Date

Apr 2014Estimated

Completion Date

Apr 2014Estimated

First Submitted Date

Mar 29, 2013

First Submission Date that Met QC Criteria

Apr 5, 2013

First Posted Date

Apr 8, 2013Estimated

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Apr 9, 2013

Last Update Posted Date

Apr 10, 2013Estimated

Oversight Module

Has Data Monitoring Committee (DMC)

Is FDA Regulated Drug

Not provided

Is FDA Regulated Device

Not provided

Is Unapproved Device

Not provided

Pediatric Postmarket Surveillance of a Device Product

Not provided

Product Exported from US

Not provided

FDAAA801 Violation

Not provided

Description Module

Brief Summary

The management of acute diverticulitis maybe better if we have prognostic markers of evolution.

Hypothesis: C-reactive protein maybe a good prognostic marker of evolution of acute diverticulitis.

The investigators need to know the values of C-reactive protein to predict evolution of acute diverticulitis.

Detailed Description

A prospective observational study. All the patients with TC-diagnosis of acute diverticulitis (AD) had a C-reactive protein (PCR) in the initial blood test.

The investigators will predict evolution of AD with the PCR initial.

Design Module

Study Type

Observational

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Yes

Target Follow-Up Duration

30 Days

Phases

Not provided

Interventional Study Design

Allocation

Not provided

Intervention Model

Biospecimen

No data available

No data is available for this block.

Enrollment

30Estimated

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
Acute Diverticulitis		We measured C-reactive protein in all the patients diagnosed with acute diverticulitis	Other: C-reactive protein

Interventions

Name	Type	Description	Arm Group Labels	Other Names
C-reactive protein	Other	measured C-reactive protein in all patients with acute diverticulitis	Acute Diverticulitis

Measure	Description	Time Frame
C-Reactive Protein		24 Hours

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

Acute Diverticulitis

Exclusion Criteria:

Other Abdominal Pathologies

Accepts Healthy Volunteers

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

18 Years

Maximum Age

90 Years

Standard Ages

AdultOlder Adult

Study Population

All Patients with Acute Diverticulitis

Sampling Method

Non-Probability Sample

Contacts/Locations Module

Central Contacts

Name	Role	Phone	Extension	Email
MORA L. LAURA, MD	Contact	34639101033		Lmora@tauli.cat

Overall Officials

Name	Affiliation	Role
MORA LAURA, MD	Corporacion Parc Tauli	Principal Investigator

Locations

Facility	Status	City	State	ZIP	Country	Contacts
Corporacion Parc Tauli		Sabadell	Barcelona	08208	Spain

Intervention Browse Module

MeSH Terms

ID	Term
D002097	C-Reactive Protein

Ancestor Terms

ID	Term
D000418	Albumins
D011506	Proteins
D000602	Amino Acids, Peptides, and Proteins
D000209	Acute-Phase Proteins

Browse Leaves

Not provided

Browse Branches

Not provided